$0.968000
-0.03-3.20%
At Close: -
$0.989000
0.022.17%
After Hours: Aug 23, 7:26 PM EDT
15 minutes delayed
Adial Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adial Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-2.19 | $-0.35 | -525.7 % |
Mar 2024 | 2024-04-01 | $-0.37 | $-0.47 | 21.3 % |
Sep 2023 | 2023-11-14 | $-1.14 | $-1.13 | -0.88 % |
Jun 2023 | 2023-08-21 | $-1.33 | $-1.50 | 1133.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Adial Pharmaceuticals (ADIL) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.59, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.